drugset / Trial / NCT02241811

Wound Treatment With 3% Sodium Pentaborate Pentahydrate

NCT02241811 ↗

RandomizedSingle-groupSingle-blindTreatment

Summary

Chronic foot wounds which is very difficult to treat are common especially in diabetic and peripheral arterial or venous insufficiency patients. This research is aim to observe the foot wound's recovery with 3% Sodium pentaborate pentahydrate hydrogel.

Timeline

Start
2014-09
Primary completion
2021-12
Completion
2023-12

Drugs

EvaluationDrugModalityDoseRoute
Subject PENTABORATE Small molecule 3 % Topical

Indications

No indication recorded.